Search

Some of the UK and China's leading data scientists will team up at a new London lab thanks to a partnership between Imperial College London and Zhejiang University (ZJU).

Cell therapies hold the promise of more effective treatments for a range of diseases, but they face a long and expensive route to market. The key is to reduce risk and attract investors, says Keith Thompson, head of the UK Cell Therapy Catapult

MEPs voice strong reservations on the Transatlantic Trade and Investment Partnership negotiations to the EU Commissioner for Trade

Temporary stand-in Ferdinando Nelli Feroci is quizzed on his priorities for the next four months

Diabetes, hydrogen-powered vehicles and electronics are among the diverse range of research to receive funding

A new initiative to provide business leadership training for 20 senior managers from fast growing SMEs (Small and Medium Sized Enterprises) has just been launched by WMG, at the University of Warwick, in partnership with Santander.

The ETH Board confirmed today that Sarah Springman, Professor of Geotechnical Engineering, is to become the new Rector of ETH Zurich. Alongside Lino Guzzella, who will move from the office of Rector to the Presidency, Springman will help shape the future of ETH Zurich as part of the Executive Board from January 2015.

Following Premier Li Keqiang's visit to the UK, the President of Imperial College London is leading a delegation to China to promote research, innovation and education ties between the two countries.

The uncertainty sparked by the US ruling that the BRCA1 and BRCA2 breast cancer genes are not patentable is holding back the development of diagnostics and therapies, says patent lawyer Adrian Tombling

Taking a page out of nature’s handbook, Novozymes deploys enzymes to help (re) create a bio-based society

Collaboration will work on developing analytics and on skills development

Commission is formed in the wake of critical analysis from the OECD and in the face of protests from French scientists

Commission's President-designate made the pledge in the European Parliament this week

A sole focus on computer simulation has been rejected by researchers, who say more basic research is needed before the brain can usefully be modelled in silico

ESADE views the ECB's measures as "insufficient" and predicts that unconventional monetary-policy measures will be introduced by the end of the year

His tremendous passion for physics and discovering the unexplored concepts has always been astonishing to most of his colleagues. The initiation of BNP Science Project group, his tendency to tackle problems from different angles and thinking about new ideas even over coffee and lunch breaks have inspired many of the Bionanophotonics Division group members. ​

The CEOs of Ablynx and uniQure, at a Science|Business event, tell their growth stories – and what Europe needs to do if there are to be more companies like theirs bringing new medicines to market

Pharmaceutical R&D functions at its best in small, agile and innovative SMEs. Replacing state subsidies and grant funding for research with start-up and development capital, would bring productivity improvements, says Mark Bloomfield, CEO of French biotech Polyplus Transfection

Winners of European Research Council Proof-of-Concept grants pitched their innovative ideas to investors and stakeholders at a Science|Business Innovation Board event last week.